Lipoproteins in inflammation and sepsis. I. Basic science (Q36648788)

15 August 2017

1 reference

title

Lipoproteins in inflammation and sepsis. I. Basic science (English)

1 reference

15 August 2017

0 references

Christoph Thiemermann

series ordinal

4

object named as

Christoph Thiemermann

1 reference

15 August 2017

2

Marika Collin

1 reference

15 August 2017

Oliver Murch

1

1 reference

PubMed ID

17093985

15 August 2017

Charles J Hinds

series ordinal

3

1 reference

PubMed ID

17093985

15 August 2017

language of work or name

1 reference

9 November 2006

1 reference

15 August 2017

Intensive Care Medicine

1 reference

15 August 2017

33

1 reference

15 August 2017

1

1 reference

15 August 2017

13-24

1 reference

https://scigraph.springernature.com/pub.10.1007/s00134-006-0432-y

15 August 2017

0 references

cites work

Nitric oxide and septic shock

1 reference

https://api.crossref.org/works/10.1007%2FS00134-006-0432-Y

Up-regulation of endothelial nitric oxide synthase inhibits pulmonary leukocyte migration following lung ischemia-reperfusion in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-006-0432-Y

Reconstituted high density lipoprotein inhibits physiologic and tumor necrosis factor alpha responses to lipopolysaccharide in rabbits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-006-0432-Y

Protein-free phospholipid emulsion treatment improved cardiopulmonary function and survival in porcine sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-006-0432-Y

Year in review in intensive care medicine, 2004. III. Outcome, ICU organisation, scoring, quality of life, ethics, psychological problems and communication in the ICU, immunity and hemodynamics during sepsis, pediatric and neonatal critical care, ex

21 January 2018

1 reference

12 December 2020

Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock

1 reference

12 December 2020

Apolipoprotein E protects against bacterial lipopolysaccharide-induced lethality. A new therapeutic approach to treat gram-negative sepsis.

1 reference

12 December 2020

Therapeutic effects of lysophosphatidylcholine in experimental sepsis

1 reference

12 December 2020

On the role and fate of LPS-dephosphorylating activity in the rat liver

1 reference

12 December 2020

Comparison of the effects of aminoguanidine and N omega-nitro-L-arginine methyl ester on the multiple organ dysfunction caused by endotoxaemia in the rat.

1 reference

12 December 2020

Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial

1 reference

12 December 2020

Modulation of endotoxic activity of lipopolysaccharide by high-density lipoprotein

1 reference

12 December 2020

Current understanding of the metabolism and biological actions of HDL.

1 reference

12 December 2020

Selective inhibition of the activity of inducible nitric oxide synthase prevents the circulatory failure, but not the organ injury/dysfunction, caused by endotoxin.

1 reference

12 December 2020

Involvement of transcription factors in plasma HDL protection against TNF-alpha-induced vascular cell adhesion molecule-1 expression

1 reference

12 December 2020

Lipid composition and lipopolysaccharide binding capacity of lipoproteins in plasma and lymph of patients with systemic inflammatory response syndrome and multiple organ failure

1 reference

12 December 2020

Inhibition of endotoxin-induced activation of human monocytes by human lipoproteins

1 reference

12 December 2020

High density lipoprotein (HDL) reduces renal ischemia/reperfusion injury.

1 reference

12 December 2020

Human recombinant apolipoprotein E redirects lipopolysaccharide from Kupffer cells to liver parenchymal cells in rats In vivo.

1 reference

12 December 2020

Lipoproteins inhibit macrophage activation by lipoteichoic acid.

1 reference

12 December 2020

Inhibition of LPS- and CpG DNA-induced TNF-alpha response by oxidized phospholipids

1 reference

12 December 2020

High-density lipoproteins reduce the intestinal damage associated with ischemia/reperfusion and colitis

1 reference

12 December 2020

Sphingosine 1-phosphate induces antimicrobial activity both in vitro and in vivo

1 reference

12 December 2020

A single intravenous dose of endotoxin rapidly alters serum lipoproteins and lipid transfer proteins in normal volunteers

1 reference

12 December 2020

Reconstituted high-density lipoprotein reduces LPS-stimulated TNF alpha

1 reference

12 December 2020

Sphingosine-1-phosphate prevents tumor necrosis factor-{alpha}-mediated monocyte adhesion to aortic endothelium in mice

1 reference

12 December 2020

High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase

1 reference

12 December 2020

Protective effects of reconstituted high-density lipoprotein in rabbit gram-negative bacteremia models

1 reference

12 December 2020

Lipopolysaccharide is transferred from high-density to low-density lipoproteins by lipopolysaccharide-binding protein and phospholipid transfer protein.

1 reference

12 December 2020

Cytokine response by monocytes and macrophages to free and lipoprotein-bound lipopolysaccharide

1 reference

12 December 2020

Sphingosine 1-phosphate receptors mediate stimulatory and inhibitory signalings for expression of adhesion molecules in endothelial cells

1 reference

12 December 2020

Dysregulation of the immune response in severe sepsis

1 reference

12 December 2020

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

1 reference

12 December 2020

Year in review in intensive care medicine, 2004. I. Respiratory failure, infection, and sepsis

1 reference

12 December 2020

LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria

1 reference

12 December 2020

Year in review in intensive care medicine, 2004. II. Brain injury, hemodynamic monitoring and treatment, pulmonary embolism, gastrointestinal tract, and renal failure

1 reference

12 December 2020

Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor.

1 reference

12 December 2020

High density lipoprotein-associated lysosphingolipids reduce E-selectin expression in human endothelial cells

1 reference

12 December 2020

Reconstituted high-density lipoprotein attenuates organ injury and adhesion molecule expression in a rodent model of endotoxic shock

1 reference

12 December 2020

Neutralization of endotoxin by a phospholipid emulsion in healthy volunteers.

1 reference

12 December 2020

The modification of biophysical and endotoxic properties of bacterial lipopolysaccharides by serum

1 reference

12 December 2020

Role of the tissue factor pathway in the pathogenesis and management of multiple organ failure

1 reference

12 December 2020

High-density lipoproteins in sepsis and septic shock: metabolism, actions, and therapeutic applications

1 reference

12 December 2020

Activated protein C mediates novel lung endothelial barrier enhancement: role of sphingosine 1-phosphate receptor transactivation

1 reference

12 December 2020

Paraoxonase activity in high-density lipoproteins: a comparison between healthy and obese females

1 reference

12 December 2020

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

1 reference

12 December 2020

In vivo protection against endotoxin by plasma high density lipoprotein

1 reference

12 December 2020

Reduction of febrile response to bacterial polysaccharide following incubation with serum

1 reference

12 December 2020

Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein

1 reference

12 December 2020

Role for circulating lipoproteins in protection from endotoxin toxicity.

1 reference

12 December 2020

In vitro inactivation of bacterial endotoxin by human lipoproteins and apolipoproteins

1 reference

12 December 2020

Remodelling of high density lipoproteins by plasma factors

1 reference

12 December 2020

Prevention of endotoxin-induced monokine release by human low- and high-density lipoproteins and by apolipoprotein A-I

1 reference

12 December 2020

Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock*

1 reference

12 December 2020

1 reference

12 December 2020

Plasma lipoproteins promote the release of bacterial lipopolysaccharide from the monocyte cell surface

1 reference

12 December 2020

Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death

1 reference

12 December 2020

Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice

1 reference

12 December 2020

High density lipoproteins reduce organ injury and organ dysfunction in a rat model of hemorrhagic shock.

1 reference

12 December 2020

High-density lipoprotein: multipotent effects on cells of the vasculature.

1 reference

12 December 2020

High density lipoproteins (HDL) interrupt the sphingosine kinase signaling pathway. A possible mechanism for protection against atherosclerosis by HDL

1 reference

12 December 2020

Lipopolysaccharide-binding protein and phospholipid transfer protein release lipopolysaccharides from gram-negative bacterial membranes

1 reference

12 December 2020

The epidemiology of sepsis in the United States from 1979 through 2000

1 reference

12 December 2020

High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules

1 reference

12 December 2020

What is the most effective strategy for managing diabetic dyslipidaemia?

1 reference

12 December 2020

Deaths: final data for 1997.

1 reference

12 December 2020

High density lipoproteins in the intersection of diabetes mellitus, inflammation and cardiovascular disease

1 reference

12 December 2020

Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids

1 reference

12 December 2020

New function for high density lipoproteins. Their participation in intravascular reactions of bacterial lipopolysaccharides

1 reference

12 December 2020

Suppression of HMGB1 release by stearoyl lysophosphatidylcholine:an additional mechanism for its therapeutic effects in experimental sepsis

1 reference

12 December 2020

The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study

1 reference

12 December 2020

Effect of administration of a phospholipid emulsion on the initial response of horses administered endotoxin

1 reference

12 December 2020

Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients

1 reference

12 December 2020

Regulation of sphingosine 1-phosphate-induced endothelial cytoskeletal rearrangement and barrier enhancement by S1P1 receptor, PI3 kinase, Tiam1/Rac1, and alpha-actinin

1 reference

12 December 2020

The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis

1 reference

12 December 2020

10.1007/S00134-006-0432-Y

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17093985